Back to search
FDAFDA · Food and drugs·Recall number D-0093-2019

Amlodipine/Valsartan HCTZ 10 mg/320 mg/25 mg tablets, HDPE 90 cc bottles in cardboard trays Original NDC 13668-0325-30 Repackaged NDC 70518-1220-00

Published October 31, 2018 · Recall initiated: August 24, 2018

Summary

FDA records drug Class II recall D-0093-2019, published October 31, 2018 and initiated August 24, 2018. Recalling firm: RemedyRepack Inc.; Status: Terminated; Reported quantity: 2 bottles of 90 tablets (180 tablets); Lot: Lot # B0438903-052118 70518-1220-00. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Detection of trace amounts of NDMA, a possible impurity or contaminant in an active pharmaceutical ingredient.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
RemedyRepack Inc.
Distributor
Product was distributed to a medical facility in South Carolina
Lot
Lot # B0438903-052118 70518-1220-00
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Amlodipine/Valsartan HCTZ 10 mg/320 mg/25 mg tablets, HDPE 90 cc bottles in cardboard trays Original NDC 13668-0325-30 Repackaged NDC 70518-1220-00 recalled?

Yes. FDA published recall D-0093-2019 on October 31, 2018. Reported hazard: CGMP Deviations: Detection of trace amounts of NDMA, a possible impurity or contaminant in an active pharmaceutical ingredient.

What should I do if I have this product?

Voluntary: Firm initiated · Letter